Calcineurin inhibitor sparing regimens using m-target of rapamycin inhibitors: an opportunity to improve cardiovascular risk following kidney transplantation?
Maintenance therapy with calcineurin inhibitors (CNIs) increases cardiovascular risk. Use of the m-TOR inhibitors everolimus or sirolimus to minimize CNI exposure is usually undertaken to preserve renal function following kidney transplantation, but may also improve cardiovascular risk status. Recen...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2011
|
| In: |
Transplant international
Year: 2011, Jahrgang: 24, Heft: 1, Pages: 30-42 |
| ISSN: | 1432-2277 |
| DOI: | 10.1111/j.1432-2277.2010.01140.x |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1111/j.1432-2277.2010.01140.x Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1432-2277.2010.01140.x 
|
| Verfasserangaben: | Martin Zeier and Markus van der Giet |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1828307319 | ||
| 003 | DE-627 | ||
| 005 | 20230710095410.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221222s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/j.1432-2277.2010.01140.x |2 doi | |
| 035 | |a (DE-627)1828307319 | ||
| 035 | |a (DE-599)KXP1828307319 | ||
| 035 | |a (OCoLC)1389738617 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Zeier, Martin |e VerfasserIn |0 (DE-588)1026480302 |0 (DE-627)726772356 |0 (DE-576)371826438 |4 aut | |
| 245 | 1 | 0 | |a Calcineurin inhibitor sparing regimens using m-target of rapamycin inhibitors |b an opportunity to improve cardiovascular risk following kidney transplantation? |c Martin Zeier and Markus van der Giet |
| 264 | 1 | |c 2011 | |
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online: 19 July 2010 | ||
| 500 | |a Gesehen am 22.12.2022 | ||
| 520 | |a Maintenance therapy with calcineurin inhibitors (CNIs) increases cardiovascular risk. Use of the m-TOR inhibitors everolimus or sirolimus to minimize CNI exposure is usually undertaken to preserve renal function following kidney transplantation, but may also improve cardiovascular risk status. Recent studies of early conversion from CNI to m-TOR inhibitors have shown a numerical improvement in the incidence of hypertension, but results are not clear-cut. Dyslipidaemia, in contrast, is more frequent under m-TORs than with CNI-based immunosuppression. New-onset diabetes is rare (≤5%) using modern m-TOR regimens, for example, everolimus and reduced-exposure CNI. Renal function improvement with m-TOR inhibitor regimens versus CNIs would also be expected to improve cardiovascular risk. Moreover, m-TOR-based CNI-minimization regimens are not associated with proteinuria, a known cardiovascular risk factor, with the possible exception of late conversion in patients with poor renal function. Interestingly, m-TOR inhibitors may also exert cardioprotective effects. Animal data suggest that m-TORs may restrict the pathogenesis of atherosclerosis, consistent with preliminary clinical data that conversion from CNIs to everolimus can stabilize markers for arterial stiffness. In conclusion, use of m-TORs has the potential to lessen the toll of cardiovascular disease following kidney transplantation - an opportunity that merits further exploration. | ||
| 650 | 4 | |a calcineurin inhibitors | |
| 650 | 4 | |a cardiovascular | |
| 650 | 4 | |a cardiovascular risk | |
| 650 | 4 | |a everolimus | |
| 650 | 4 | |a m-TOR inhibitors | |
| 650 | 4 | |a sirolimus | |
| 700 | 1 | |a Giet, Markus van der |e VerfasserIn |0 (DE-588)101440584X |0 (DE-627)705224228 |0 (DE-576)348744099 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Transplant international |d Lausanne : Frontiers Media, 1988 |g 24(2011), 1, Seite 30-42 |h Online-Ressource |w (DE-627)254909744 |w (DE-600)1463183-0 |w (DE-576)074754173 |x 1432-2277 |7 nnas |a Calcineurin inhibitor sparing regimens using m-target of rapamycin inhibitors an opportunity to improve cardiovascular risk following kidney transplantation? |
| 773 | 1 | 8 | |g volume:24 |g year:2011 |g number:1 |g pages:30-42 |g extent:13 |a Calcineurin inhibitor sparing regimens using m-target of rapamycin inhibitors an opportunity to improve cardiovascular risk following kidney transplantation? |
| 856 | 4 | 0 | |u https://doi.org/10.1111/j.1432-2277.2010.01140.x |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1432-2277.2010.01140.x |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20221222 | ||
| 993 | |a Article | ||
| 994 | |a 2011 | ||
| 998 | |g 1026480302 |a Zeier, Martin |m 1026480302:Zeier, Martin |d 910000 |d 910100 |d 50000 |e 910000PZ1026480302 |e 910100PZ1026480302 |e 50000PZ1026480302 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1828307319 |e 4237677729 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"recId":"1828307319","note":["Published online: 19 July 2010","Gesehen am 22.12.2022"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"given":"Martin","family":"Zeier","role":"aut","display":"Zeier, Martin","roleDisplay":"VerfasserIn"},{"display":"Giet, Markus van der","roleDisplay":"VerfasserIn","role":"aut","family":"Giet","given":"Markus van der"}],"title":[{"title":"Calcineurin inhibitor sparing regimens using m-target of rapamycin inhibitors","subtitle":"an opportunity to improve cardiovascular risk following kidney transplantation?","title_sort":"Calcineurin inhibitor sparing regimens using m-target of rapamycin inhibitors"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedKey":"1988","publisher":"Frontiers Media ; Springer ; Blackwell ; Wiley-Blackwell","dateIssuedDisp":"1988-","publisherPlace":"Lausanne ; Berlin ; Heidelberg ; New York, NY ; Oxford [u.a.] ; Oxford [u.a.]"}],"id":{"issn":["1432-2277"],"zdb":["1463183-0"],"eki":["254909744"],"doi":["10.1111/(ISSN)1432-2277"]},"pubHistory":["1.1988 -"],"part":{"pages":"30-42","issue":"1","year":"2011","extent":"13","text":"24(2011), 1, Seite 30-42","volume":"24"},"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Calcineurin inhibitor sparing regimens using m-target of rapamycin inhibitors an opportunity to improve cardiovascular risk following kidney transplantation?Transplant international","note":["Gesehen am 11.07.2022","Teils ungezählte Beil.: Supplement"],"recId":"254909744","language":["eng"],"title":[{"title_sort":"Transplant international","title":"Transplant international","subtitle":"official journal of the European Society for Organ Transplantation and the European Liver Transplant Association"}]}],"physDesc":[{"extent":"13 S."}],"name":{"displayForm":["Martin Zeier and Markus van der Giet"]},"id":{"doi":["10.1111/j.1432-2277.2010.01140.x"],"eki":["1828307319"]},"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"2011"}]} | ||
| SRT | |a ZEIERMARTICALCINEURI2011 | ||